Phibro Animal Health (PAHC) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Phibro Animal Health Revenue Highlights

Latest Revenue (Y)

$1.30B

Latest Revenue (Q)

$309.26M

Main Segment (Y)

Vaccines

Main Geography (Y)

UNITED STATES

Phibro Animal Health Revenue by Period

Phibro Animal Health Revenue by Year

Date	Revenue	Change
2025-06-30	$1.30B	27.37%
2024-06-30	$1.02B	4.07%
2023-06-30	$977.89M	3.78%
2022-06-30	$942.30M	13.07%
2021-06-30	$833.35M	4.12%
2020-06-30	$800.40M	-3.33%
2019-06-30	$828.00M	0.98%
2018-06-30	$820.00M	7.29%
2017-06-30	$764.30M	1.70%
2016-06-30	$751.50M	0.39%
2015-06-30	$748.59M	8.19%
2014-06-30	$691.90M	5.93%
2013-06-30	$653.15M	-0.15%
2012-06-30	$654.10M	5.78%
2011-06-30	$618.33M	4.06%
2010-06-30	$594.20M	10.63%
2009-06-30	$537.10M	5.03%
2008-06-30	$511.40M	12.89%
2007-06-30	$453.00M	13.70%
2006-06-30	$398.40M	9.33%
2005-06-30	$364.40M	2.82%
2004-06-30	$354.40M	4.91%
2003-06-30	$337.80M	2.77%
2002-06-30	$328.70M	2.82%
2001-06-30	$319.70M	-1.02%
2000-06-30	$323.00M	-

Phibro Animal Health generated $1.30B in revenue during NA 2025, up 27.37% compared to the previous quarter, and up 161.95% compared to the same period a year ago.

Phibro Animal Health Revenue by Quarter

Date	Revenue	Change
2024-12-31	$309.26M	18.75%
2024-09-30	$260.43M	-4.66%
2024-06-30	$273.16M	3.78%
2024-03-31	$263.22M	5.31%
2023-12-31	$249.94M	8.06%
2023-09-30	$231.30M	-9.31%
2023-06-30	$255.05M	3.82%
2023-03-31	$245.67M	0.42%
2022-12-31	$244.65M	5.21%
2022-09-30	$232.52M	-8.92%
2022-06-30	$255.30M	6.54%
2022-03-31	$239.62M	2.97%
2021-12-31	$232.71M	8.41%
2021-09-30	$214.66M	-2.56%
2021-06-30	$220.30M	4.05%
2021-03-31	$211.73M	2.71%
2020-12-31	$206.15M	5.61%
2020-09-30	$195.19M	5.00%
2020-06-30	$185.90M	-11.79%
2020-03-31	$210.74M	-1.53%
2019-12-31	$214.01M	12.80%
2019-09-30	$189.72M	-6.95%
2019-06-30	$203.90M	-0.89%
2019-03-31	$205.74M	-5.72%
2018-12-31	$218.22M	9.03%
2018-09-30	$200.15M	-5.50%
2018-06-30	$211.80M	1.38%
2018-03-31	$208.91M	1.47%
2017-12-31	$205.88M	6.44%
2017-09-30	$193.41M	-0.71%
2017-06-30	$194.80M	2.60%
2017-03-31	$189.86M	-0.91%
2016-12-31	$191.60M	1.92%
2016-09-30	$187.99M	-0.64%
2016-06-30	$189.20M	3.13%
2016-03-31	$183.46M	-4.33%
2015-12-31	$191.77M	2.49%
2015-09-30	$187.12M	1.17%
2015-06-30	$184.95M	-1.36%
2015-03-31	$187.50M	-0.63%
2014-12-31	$188.69M	0.66%
2014-09-30	$187.46M	2.06%
2014-06-30	$183.68M	6.01%
2014-03-31	$173.27M	0.30%
2013-12-31	$172.74M	6.48%
2013-09-30	$162.23M	-1.20%
2013-06-30	$164.20M	0.93%
2013-03-31	$162.69M	-0.90%
2012-12-31	$164.16M	1.27%
2012-09-30	$162.10M	6.79%
2009-12-31	$151.80M	11.37%
2009-09-30	$136.30M	-2.01%
2009-06-30	$139.10M	7.83%
2009-03-31	$129.00M	1.02%
2008-12-31	$127.70M	-6.24%
2008-09-30	$136.20M	-4.95%
2008-06-30	$143.30M	8.23%
2008-03-31	$132.40M	7.47%
2007-12-31	$123.20M	9.41%
2007-09-30	$112.60M	-8.31%
2007-06-30	$122.80M	13.28%
2007-03-31	$108.40M	-7.35%
2006-12-31	$117.00M	11.64%
2006-09-30	$104.80M	-0.38%
2006-06-30	$105.20M	4.26%
2006-03-31	$100.90M	1.20%
2005-12-31	$99.70M	7.67%
2005-09-30	$92.60M	-

Phibro Animal Health generated $309.26M in revenue during Q2 2025, up 18.75% compared to the previous quarter, and up 133.71% compared to the same period a year ago.

Phibro Animal Health Revenue Breakdown

Phibro Animal Health Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Jun 25	Jun 24	Jun 23	Jun 22	Jun 21
Vaccines	$137.15M	$120.85M	$100.00M	$88.32M	-
Animal Health	-	-	-	-	$72.94M
Performance Products	-	-	-	-	$67.07M
Mineral Nutrition	-	-	-	-	$220.56M

Phibro Animal Health's latest annual revenue breakdown by segment (product or service), as of Jun 25: Vaccines (100.00%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
Vaccines	$38.57M	$33.38M	$33.17M	$32.03M	$31.99M	$32.92M	$29.73M	$26.22M	$26.20M	$22.77M	$23.02M	-	-	-	-	-	-	-	-	-
Performance Products	-	-	-	-	-	-	-	-	$19.85M	$18.32M	$19.20M	$18.02M	$22.00M	$15.13M	$19.23M	$16.74M	$19.20M	$15.75M	$15.38M	$13.61M
Animal Health	-	-	-	-	-	-	-	-	$176.75M	$164.43M	$163.80M	$154.86M	$22.86M	$21.87M	$21.25M	$18.73M	$18.87M	$18.27M	$17.07M	$18.62M
Mineral Nutrition	-	-	-	-	-	-	-	-	$58.44M	$62.92M	$61.64M	$59.65M	$69.03M	$66.66M	$54.43M	$56.81M	$58.15M	$54.16M	$51.44M	$49.88M

Phibro Animal Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Vaccines (100.00%).

Phibro Animal Health Revenue Breakdown by Country

Annual Revenue by Country

Country	Jun 25	Jun 24	Jun 23	Jun 22	Jun 21
EMEA	$160.23M	$121.98M	$117.81M	$122.48M	-
Latin America and Canada	$298.65M	$247.71M	$219.85M	$191.05M	-
UNITED STATES	$739.92M	$584.76M	$578.77M	$561.80M	-
Asia Pacific	$97.42M	$63.23M	$61.45M	$66.93M	$58.01M
Vaccines	-	-	-	$88.32M	-
Europe Middle East And Africa	-	-	-	-	$114.13M
Latin America And Canada	-	-	-	-	$166.32M
U	-	-	-	-	$494.89M

Phibro Animal Health's latest annual revenue breakdown by geography, as of Jun 25: UNITED STATES (57.08%), Latin America and Canada (23.04%), EMEA (12.36%), and Asia Pacific (7.52%).

Quarterly Revenue by Country

Country	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
Latin America and Canada	$84.07M	$70.75M	$72.67M	$71.15M	$70.17M	$53.65M	$65.18M	$58.70M	$59.90M	$53.88M	$53.82M	$52.25M	$45.05M	$48.01M	$42.66M	-	-	-	-	-
Asia Pacific	$35.03M	$28.22M	$19.56M	$14.61M	$16.91M	$17.08M	$14.76M	$14.48M	$17.80M	$15.09M	$13.61M	$14.95M	$17.82M	$15.53M	$14.75M	$16.15M	$17.17M	$12.89M	$11.79M	$14.10M
EMEA	$57.61M	$38.91M	$32.59M	$31.13M	$32.41M	$33.17M	$29.52M	$26.88M	$32.30M	$28.17M	$27.83M	$29.52M	-	-	-	-	-	-	-	-
UNITED STATES	$201.99M	$209.94M	$184.44M	$143.55M	$153.68M	$159.31M	$140.48M	$131.29M	$145.05M	$148.53M	$149.39M	$135.80M	-	-	-	-	-	-	-	-
Vaccines	-	-	-	-	-	-	-	-	-	$26.20M	-	-	-	-	-	-	-	-	-	-
Performance Products	-	-	-	-	-	-	-	-	-	$18.32M	-	-	-	-	-	-	-	-	-	-
Mineral Nutrition	-	-	-	-	-	-	-	-	-	$62.92M	-	-	-	-	-	-	-	-	-	-
Animal Health	-	-	-	-	-	-	-	-	-	$164.43M	-	-	-	-	-	-	-	-	-	-
United States	-	-	-	-	-	-	-	-	-	-	-	-	$146.82M	$139.15M	$126.32M	-	-	-	-	-
Europe, Middle East and Africa	-	-	-	-	-	-	-	-	-	-	-	-	$29.93M	$30.03M	$30.93M	-	-	-	-	-
Latin America And Canada	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$50.52M	$37.39M	$40.66M	$37.76M	$39.21M
Europe Middle East And Africa	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$29.17M	$27.80M	$30.29M	$26.87M	$28.87M
U	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$124.44M	$129.37M	$122.31M	$118.77M	$103.71M

Phibro Animal Health's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (53.34%), Latin America and Canada (22.20%), EMEA (15.21%), and Asia Pacific (9.25%).

Phibro Animal Health Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
PAHC	Phibro Animal Health	$1.30B	$309.26M
PBH	Prestige Consumer Healthcare	$1.13B	$249.53M
SFBS	ServisFirst Bancshares	$946.12M	$247.06M
VREX	Varex Imaging	$811.00M	$212.90M
JRVR	James River Group	$707.63M	$174.84M
COLL	Collegium Pharmaceutical	$631.45M	$177.76M
LIEN	Chicago Atlantic BDC	$10.03M	$2.78M
OFIX	Orthofix Medical	-	$203.12M
RGC	Regencell Bioscience	-	-

PAHC Revenue FAQ

What is Phibro Animal Health’s yearly revenue?

Phibro Animal Health's yearly revenue for 2025 was $1.3B, representing an increase of 27.37% compared to 2024. The company's yearly revenue for 2024 was $1.02B, representing an increase of 4.07% compared to 2023. PAHC's yearly revenue for 2023 was $977.89M, representing an increase of 3.78% compared to 2022.

What is Phibro Animal Health’s quarterly revenue?

Phibro Animal Health's quarterly revenue for Q2 2025 was $309.26M, a 18.75% increase from the previous quarter (Q1 2025), and a 23.73% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $260.43M, a -4.66% decrease from the previous quarter (Q4 2024), and a 12.59% increase year-over-year (Q1 2024). PAHC's quarterly revenue for Q4 2024 was $273.16M, a 3.78% increase from the previous quarter (Q3 2024), and a 7.10% increase year-over-year (Q4 2023).

What is Phibro Animal Health’s revenue growth rate?

Phibro Animal Health's revenue growth rate for the last 3 years (2023-2025) was 32.55%, and for the last 5 years (2021-2025) was 55.54%.

What are Phibro Animal Health’s revenue streams?

Phibro Animal Health's revenue streams in n 25 are Vaccines

What is Phibro Animal Health’s main source of revenue?

For the fiscal year ending Jun 25, the largest source of revenue of Phibro Animal Health was Vaccines. This segment made a revenue of $137.15M, representing 100.00% of the company's total revenue.